In the secondary analyses based on the alternative
definition of hypertension (systolic blood pressure
> 130 mm Hg, diastolic blood pressure > 85 mm Hg or
drug), the presence of metabolic syndrome was a borderline
significant predictor of HF after adjustment for established
risk factors for HF (model B: hazard ratio 1.61, 95% CI 0.98 to
2.66). When interim myocardial infarction was also adjusted
for in addition to the established baseline risk factors for HF,
the presence of metabolic syndrome was a significant
predictor of HF (model C: hazard ratio 1.74, 95% CI 1.06 to
2.83) in the model based on the alternative definition of
hypertension. In further secondary analyses with ESR added
as a covariate, the association between metabolic syndrome
and HF was still strong and significant (hazard ratio 3.23,
95% CI 2.16 to 4.83 with ESR added to model A). When
ESRwas added to the model adjusted for established risk factors
for HF including myocardial infarction during follow up
(model C), metabolic syndrome remained a significant
predictor of HF (hazard ratio 1.73, 95% CI 1.07 to 2.81).
None of the interaction terms was significant.
In the secondary analyses based on the alternative
definition of hypertension (systolic blood pressure
> 130 mm Hg, diastolic blood pressure > 85 mm Hg or
drug), the presence of metabolic syndrome was a borderline
significant predictor of HF after adjustment for established
risk factors for HF (model B: hazard ratio 1.61, 95% CI 0.98 to
2.66). When interim myocardial infarction was also adjusted
for in addition to the established baseline risk factors for HF,
the presence of metabolic syndrome was a significant
predictor of HF (model C: hazard ratio 1.74, 95% CI 1.06 to
2.83) in the model based on the alternative definition of
hypertension. In further secondary analyses with ESR added
as a covariate, the association between metabolic syndrome
and HF was still strong and significant (hazard ratio 3.23,
95% CI 2.16 to 4.83 with ESR added to model A). When
ESRwas added to the model adjusted for established risk factors
for HF including myocardial infarction during follow up
(model C), metabolic syndrome remained a significant
predictor of HF (hazard ratio 1.73, 95% CI 1.07 to 2.81).
None of the interaction terms was significant.
การแปล กรุณารอสักครู่..